Monday, November 9, 2015
- 9:00AM-11:00AM
-
Abstract Number: 1258
Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed By Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract
Genetics, Genomics and Proteomics Poster II- 9:00AM-11:00AM
-
Abstract Number: 1750
Identification of Autoantibody-Inducing CD4 T Cell (aiCD4 T cell) That Causes Systemic Lupus Erythematosus (SLE) As DOCK8+ CD4 T Cell: Proof of Concept of Self-Organized Criticality Theory
Systemic Lupus Erythematosus - Animal Models Poster I- 9:00AM-11:00AM
-
Abstract Number: 1095
Identification of Carbamylated Alpha-1-Anti-Trypsin (A1AT) As an Antigenic Target of Anti-Carp Antibodies in Patients with Rheumatoid Arthritis
B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 1616
Identification of Genes Regulating TRAIL-Induced Apoptosis in Rheumatoid Arthritis Fibroblasts-like Synoviocytes (RA FLS)
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1953
Identification of Genetic Factors Associated with Clinical Manifestations of Giant Cell Arteritis through a Stratified Large-Scale Analysis
Vasculitis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1862
Identification of Homogeneous Systemic Lupus Erythematosus (SLE) Patient Groups Using Clustered Autoantibody Reactivities
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1134
Identification of Novel Micro-RNAs in IL-1β-Stimulated OA Chondrocytes By Next-Generation Sequencing
Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis- 9:00AM-11:00AM
-
Abstract Number: 1243
Identification of the Gene Expression Signatures Predicting the Responses to Three Biologics (infliximab, tocilizumab, and abatacept) in Rheumatoid Arthritis
Genetics, Genomics and Proteomics Poster II- 9:00AM-11:00AM
-
Abstract Number: 1857
Identification of the Long Noncoding RNA NEAT1 As a Novel Inflammatory Regulator Acting through MAPK Pathway in Human Lupus
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1583
Identifying Risk Factors for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rheumatoid Arthritis - Clinical Aspects Poster II- 9:00AM-11:00AM
-
Abstract Number: 1846
IGFBP-2 As a Novel Biomarker for Disease Activity and Renal Pathology in Lupus Nephritis
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1799
IgG Levels Correlate Inversely with Proteinuria Among Participants in the Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis Trial, but Hypogammaglobulinemia Was Not Associated with an Increased Risk of Serious Infection
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session II- 9:00AM-11:00AM
-
Abstract Number: 1136
IL-1β-Induced Stress Granules Sequester COX-2 mRNA and Regulates Its Expression in Human OA Chondrocytes
Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis